GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFF) » Definitions » Debt-to-EBITDA

McKesson Europe AG (McKesson Europe AG) Debt-to-EBITDA : 1.31 (As of Mar. 2022)


View and export this data going back to 2009. Start your Free Trial

What is McKesson Europe AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

McKesson Europe AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $35 Mil. McKesson Europe AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $168 Mil. McKesson Europe AG's annualized EBITDA for the quarter that ended in Mar. 2022 was $154 Mil. McKesson Europe AG's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2022 was 1.31.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for McKesson Europe AG's Debt-to-EBITDA or its related term are showing as below:

CAKFF's Debt-to-EBITDA is not ranked *
in the Medical Distribution industry.
Industry Median: 2
* Ranked among companies with meaningful Debt-to-EBITDA only.

McKesson Europe AG Debt-to-EBITDA Historical Data

The historical data trend for McKesson Europe AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Debt-to-EBITDA Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.11 1.83 3.61 1.31

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.11 1.83 3.61 1.31

Competitive Comparison of McKesson Europe AG's Debt-to-EBITDA

For the Medical Distribution subindustry, McKesson Europe AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Debt-to-EBITDA falls into.



McKesson Europe AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

McKesson Europe AG's Debt-to-EBITDA for the fiscal year that ended in Mar. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(34.692 + 167.841) / 154.405
=1.31

McKesson Europe AG's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(34.692 + 167.841) / 154.405
=1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Mar. 2022) EBITDA data.


McKesson Europe AG  (OTCPK:CAKFF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


McKesson Europe AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (McKesson Europe AG) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines